- DocumentReduction of the peripheral blood CD56(bright) NK lymphocyte subset in FTY720-treated multiple sclerosis patientsuploaded by
Andrés de la Peña
- DocumentNatalizumab induced blood eosinophilia A retrospective pharmacovigilance cohort study and review of the literatureuploaded by
Andrés de la Peña
- DocumentImmunological Predictors of Dimethyl Fumarate‐Induced Lymphopeniauploaded by
Andrés de la Peña
- DocumentMarked neutropenia significant but rare in people with multiple sclerosis after alemtuzumab treatmentuploaded by
Andrés de la Peña
- DocumentInitial lymphocyte count and low BMI may affect fingolimod-induced lymphopeniauploaded by
Andrés de la Peña